Meyka Pro banner
Unique Fabricating, Inc.

Stay Updated with the Latest Unique Fabricating, Inc. UFAB News in Real Time

Find UFAB news now at Meyka AI. Stay informed with the latest Unique Fabricating, Inc. stocks updates, including price news, market analysis, and expert insights.

UFABAMEX
Consumer CyclicalAuto - Parts
$0.17
$0.04(17.56%)
U.S. Market opens in 49h 29m
Block Ordered to Pay $120M CFPB Restitution for Cash App Fraud Failures
📅 10 hours ago

Block Ordered to Pay $120M CFPB Restitution for Cash App Fraud Failures

Block must pay $45M to states and $75M-$120M to Cash App users via CFPB restitution for fraud failures, account security gaps, and inadequate customer support.

Read more 12
Bitcoin Price Today: BTC Soars 8% to $74,982 as Crypto Rally Explodes; Ethereum, XRP Surge
📅 23 hours ago

Bitcoin Price Today: BTC Soars 8% to $74,982 as Crypto Rally Explodes; Ethereum, XRP Surge

Bitcoin surged 8% to $74,982 on Friday, August 21, 2026, extending a powerful weekly rally. The cryptocurrency has now climbed nearly 20% since Monday, fueled by a surprise US Treasury policy shift. Ethereum jumped toward $2,300, gaining roughly 18% in 24 hours, while XRP surged past $1.25.  Total crypto market capitalization reached $2.56 trillion, up…

Read more 12
Tech Stocks to Watch: Alphabet Lifts 2026 Capex Forecast to $195B-205B
📅 1 day ago

Tech Stocks to Watch: Alphabet Lifts 2026 Capex Forecast to $195B-205B

Alphabet is spending more to keep up with demand for artificial intelligence. On July 22, 2026, the Google parent raised its 2026 capital expenditure forecast to $195 billion-$205 billion, up from $180 billion-$190 billion. The increase comes as Google Cloud revenue jumped 82% to $24.8 billion in the second quarter. As AI demand drives higher…

Read more 12
Shiprocket Stock Jumps 8% to ₹155.69 as Goldman Sachs Buys 40 Lakh+ Shares
📅 2 days ago

Shiprocket Stock Jumps 8% to ₹155.69 as Goldman Sachs Buys 40 Lakh+ Shares

Shiprocket shares jumped 8.5% to ₹155.69 on August 20, 2026, extending the gains seen after the company’s stock-market debut. The move came after Goldman Sachs bought 40.24 lakh Shiprocket shares at ₹131 each through a bulk deal on August 19. Shiprocket had already listed at a 35% premium to its ₹97 IPO price. Investors are…

Read more 12
Crypto Prices Today: Bitcoin Hits $69,551, Ethereum Gains 17.74% as Hyperliquid Surges 20.97%
📅 2 days ago

Crypto Prices Today: Bitcoin Hits $69,551, Ethereum Gains 17.74% as Hyperliquid Surges 20.97%

Crypto prices surged sharply on Thursday, August 20, 2026, breaking weeks of sideways trading. Bitcoin jumped to $69,551, gaining roughly 8% in 24 hours. Ethereum climbed 17.74% to reclaim the $2,000 level, while Hyperliquid’s HYPE token surged 20.97%. The rally followed a surprise US Treasury announcement to double its long-dated bond buyback operations.  Total crypto…

Read more 12
NVDA Stock, AMD Stock, Micron and Broadcom Gain as AI Spending Estimates Rise
📅 2 days ago

NVDA Stock, AMD Stock, Micron and Broadcom Gain as AI Spending Estimates Rise

AI spending estimates are rising again, giving semiconductor stocks a fresh boost. On August 7, 2026, Goldman Sachs estimated global AI investment could reach about $1 trillion this year, above widely cited hyperscaler spending forecasts. That outlook is supporting demand for AI chips, memory and networking hardware. As a result, NVDA stock, AMD stock, Micron…

Read more 12
DOJ Defends Comey Prosecution Over Seashell Post on August 20
📅 2 days ago

DOJ Defends Comey Prosecution Over Seashell Post on August 20

Federal prosecutors defend charges against James Comey over seashell post arranged as ‘8647,’ claiming an objective viewer could read it as ‘Kill President Trump.’ Comey denies the threat allegation.

Read more 12
Moderna Soars 177% After Melanoma Vaccine Clears Phase 3 Trial on August 20
📅 2 days ago

Moderna Soars 177% After Melanoma Vaccine Clears Phase 3 Trial on August 20

Moderna stock jumped 177% after its melanoma vaccine met Phase 3 trial endpoints. The personalized mRNA therapy showed significant improvements over standard treatment in over 1,100 patients.

Read more 12
Moderna Soars 177% on Melanoma Vaccine Win; Merck Gains 12%
📅 2 days ago

Moderna Soars 177% on Melanoma Vaccine Win; Merck Gains 12%

Moderna jumped 177% and Merck rose 12% after announcing the first Phase 3 win for an mRNA cancer vaccine. The personalized treatment reduced melanoma recurrence risk significantly.

Read more 12

UFAB News FAQ